ReviewPharmaceutics2021

Signaling Pathway Inhibitors, miRNA, and Nanocarrier-Based Pharmacotherapeutics for the Treatment of Lung Cancer: A Review.

Shadab Md et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.